Nanjing, May 8 (Xinhua) by Liu Weiwei, the high-end medical device industry development conference of Suzhou high tech Zone was held on the 8th. The three-year action plan (2021-2023) of Suzhou high tech Zone to promote the high-quality development of high-end medical device and biomedical industry chain was released, and the construction of "Taihu medical Valley medpark" was launched.

The three-year action plan of Suzhou high tech Zone to promote the high-quality development of high-end medical devices and biomedical industry chain (2021-2023) identifies five main directions: high-end medical devices, innovative drugs, cutting-edge diagnosis and treatment technology, public health emergency management system support industry, and industry chain supporting service system industry. Suzhou high tech Zone will strive to add more than 200 high-end medical device and biomedical enterprises every year, and the revenue scale will reach 80 billion yuan in 2023.

The "action plan" completes the "three major projects" of industrial agglomeration, innovation driven promotion and industrial ecological optimization through the implementation of "ten tasks" including fast leading projects and enterprise recruitment, cultivation of "chain owner" enterprises in the industrial chain, acceleration of construction investment in key industrialization projects, acceleration of transformation of innovation achievements, promotion of collaborative innovation level in the industrial chain, and continuous strengthening of financial capital support.

On the spot, the Management Committee of Suzhou high tech Zone signed contracts with five strategic cooperation organizations, including China Medical Device Industry Association, China Society of Biomedical Engineering, and China Medical Equipment Association, 10 industrialization projects, including Boston science and Yuyue medical, 10 scientific and technological innovation projects, including Kangqi intelligence and Haoben biology, and with Yunfeng fund and Sequoia Capital and other 10 investment institutions signed contracts.

On the same day, four industrial supporting centers, including the medical device industry development center, the first loan service center for science and technology enterprises, the medical device compliance research center, and the precise cancer molecular diagnosis center, were unveiled, and six laboratories, including the joint innovation laboratory for advanced in vitro diagnostic technology of Suzhou Institute of medical technology, Chinese Academy of Sciences, and the joint innovation laboratory for organ chips of Suzhou Institute of medical devices, Southeast University, were unveiled.

The construction of "medpark of Taihu medical Valley" was started. The project is located in the south of Kunlun mountain road and the east of Fuchunjiang road in Suzhou high tech Zone, covering an area of about 156 mu. It is planned to build three bases including gazelle planning enterprise base, unicorn breeding base and listed company base, and four clusters including cardiovascular equipment cluster, biomedical materials cluster, high-end medical imaging cluster and molecular diagnosis cluster.

In recent years, Suzhou high tech Zone has seized the development of medical devices. During the 13th Five Year Plan period, the average annual growth rate of the output value of related industries is over 30%. It has gathered more than 370 leading talents in the field of medical devices, and more than 400 medical device and biomedical enterprises, with an output value of 20 billion yuan in 2020（ (end)